CPD – Evaluation of an emerging C15 across 12 disease based systems

Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems- Demonstrated broad and beneficial activities of C15:0, including many that were improved upon a leading omega-3, support C15:0’s role as an emerging essential fatty acid relevant to both physical and mental health. – This study built on the existing literature of C15:0’s anti-cancer and antimicrobial properties, as well as being the first to demonstrate the potential for C15:0 to help manage depression and autoimmune diseases. – Given the growing and repeated evidence of C15:0 as a beneficial odd-chain saturated fatty acid, there is a need to reevaluate current nutritional guidelines that continue to recommend lowered intake of all dietary saturated fats.